Through third party distribution Dechra built a solid foundation in Canada with its core CAP portfolio as well as an assortment of other CAP brands focused in the dermatology and ophthalmology segments.
As part of our geographic expansion, a decision was made to establish a Canadian subsidiary. After hiring a Country Manager in February 2014 the process began with the incorporation of the Canadian business with offices being established in Pointe-Claire, Quebec.
With approximately 3,400 clinics practicing companion animal medicine in Canada, it was clear that the team would need to be strategically positioned in order to maximize our return on investment. Focusing on hiring the best people with strong connections in the industry, five Territory Sales Managers began selling in January 2015. These field based representatives are supported by an office based Operations Manager and a recently hired Technical Services Veterinarian.
As of April 2015 we are selling exclusively the range of Dechra products. This transition from third party distribution did not happen without a few bumps in the road but we are now seeing very positive momentum. In the 2015 financial year the Canadian business achieved sales targets for Vetoryl, Felimazole and the dermatology range and saw strong momentum in the remainder of the portfolio as we came out of our distribution agreements.
While working to build on our established sales foundation, a great deal of emphasis has been put into creating a strong Dechra brand. Working with members of the global team, we have begun the ongoing process of developing and delivering materials that support our customers and their patients.
Looking forward we will be expanding our geographic reach across Canada by adding additional Territory Sales Managers to support our organic growth with a focus on our core brands. We have recently received approval for Osphos thereby expanding our portfolio into the Equine segment.